IE50376B1 - Acid addition salts of 16b-monoquaternary ammonium derivatives of 2b,16b-bis-piperidino-androstanes and pharmaceutical preparations containing same - Google Patents

Acid addition salts of 16b-monoquaternary ammonium derivatives of 2b,16b-bis-piperidino-androstanes and pharmaceutical preparations containing same

Info

Publication number
IE50376B1
IE50376B1 IE1593/79A IE159379A IE50376B1 IE 50376 B1 IE50376 B1 IE 50376B1 IE 1593/79 A IE1593/79 A IE 1593/79A IE 159379 A IE159379 A IE 159379A IE 50376 B1 IE50376 B1 IE 50376B1
Authority
IE
Ireland
Prior art keywords
acid
androstane
acid addition
bis
methobromide
Prior art date
Application number
IE1593/79A
Other languages
English (en)
Other versions
IE791593L (en
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of IE791593L publication Critical patent/IE791593L/xx
Publication of IE50376B1 publication Critical patent/IE50376B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
IE1593/79A 1978-09-05 1979-08-20 Acid addition salts of 16b-monoquaternary ammonium derivatives of 2b,16b-bis-piperidino-androstanes and pharmaceutical preparations containing same IE50376B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7835667 1978-09-05

Publications (2)

Publication Number Publication Date
IE791593L IE791593L (en) 1980-03-05
IE50376B1 true IE50376B1 (en) 1986-04-16

Family

ID=10499453

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1593/79A IE50376B1 (en) 1978-09-05 1979-08-20 Acid addition salts of 16b-monoquaternary ammonium derivatives of 2b,16b-bis-piperidino-androstanes and pharmaceutical preparations containing same

Country Status (20)

Country Link
US (2) US4237126A (https=)
EP (1) EP0008824B1 (https=)
JP (1) JPS5535098A (https=)
AR (1) AR228728A1 (https=)
AT (1) ATE921T1 (https=)
AU (1) AU526270B2 (https=)
CA (1) CA1134813A (https=)
DE (1) DE2962627D1 (https=)
DK (1) DK159119C (https=)
ES (1) ES483894A1 (https=)
FI (1) FI66881C (https=)
GR (1) GR72520B (https=)
HU (1) HU181847B (https=)
IE (1) IE50376B1 (https=)
IL (1) IL58080A (https=)
NO (1) NO151367C (https=)
NZ (1) NZ191462A (https=)
PH (1) PH16041A (https=)
PT (1) PT70126A (https=)
ZA (1) ZA794371B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE50675B1 (en) * 1979-12-12 1986-06-11 Akzo Nv Bis-and mono-quaternary ammonium derivatives of 2beta,16beta-dipiperidino-5alpha-androstanes,processes for their preparation and pharmaceutical preparations
IE53463B1 (en) * 1981-06-15 1988-11-23 Akzo Nv Mono-and bisquaternary ammonium derivatives of 2 beta,16 beta-d-amino-5 alpha-androstane derivatives and pharmaceutical preparations containing same
GB8709565D0 (en) * 1987-04-23 1987-05-28 Akzo Nv 2beta,16beta-diaminoandrostanes
US5238957A (en) * 1988-07-07 1993-08-24 Presidenza Del Consiglio Dei Ministri-Uffico Del Ministro Per Il Coordinamento Delle Iniziative Per La Ricerca Scientifica E Tecnologica Esters of 2,2-dimethyl-cyclopropane-carboxylic acid
US5418226A (en) * 1992-04-22 1995-05-23 Akzo N.V. Monoquaternary 2,16-bispiperidinylandrostane derivatives
HU210076B (en) * 1992-11-02 1995-01-30 Tuba Process for producing androstane derivatives substituted with quaternisaeted amino group in 16-position and for producing pharmaceutical compositions containing them
GB9302455D0 (en) * 1993-02-08 1993-03-24 Lab Inpharm N V Process for preparing a pharmaceutical preparation having neuromuscular blocking activity
US5767112A (en) * 1994-10-21 1998-06-16 Poli Industria Chimica, S.P.A. Muscle relaxant pharmaceutical compositions
US5553456A (en) * 1995-05-17 1996-09-10 Ramco, Inc. Clathrate freeze desalination apparatus and method
IT1277700B1 (it) * 1995-12-22 1997-11-11 Poli Ind Chimica Spa Processo di preparazione di 2-beta, 16-beta-diamino 3-alfa, 17-beta- diacilossi 5-alfaandrostani, bloccanti neuromuscolari a struttura
HU0402017D0 (en) * 2004-10-07 2004-12-28 Richter Gedeon Vegyeszet Environment-friend process for the synthesis of quaternary ammonio-steroids
WO2006038047A1 (en) * 2004-10-07 2006-04-13 Richter Gedeon Vegyészeti Gyár Rt. Environment-friend process for the synthesis of quaternary ammonio-steroιds
WO2006113462A2 (en) * 2005-04-15 2006-10-26 Lyotropic Therapeutics, Inc. Formulations of quaternary ammonium neuromuscular blocking agents
DE102005030423A1 (de) * 2005-06-30 2007-01-04 Inresa Arzneimittel Gmbh Neue Formulierung für Vecuroniumbromid
ATE554769T1 (de) 2006-12-06 2012-05-15 Cornell Res Foundation Inc Neuromuskuläre blocker mit mittlerer dauer und antagonisten advon
US8592451B2 (en) 2009-03-17 2013-11-26 Cornell University Reversible nondepolarizing neuromuscular blockade agents and methods for their use
US9220700B2 (en) 2009-08-19 2015-12-29 Cornell University Cysteine for physiological injection
WO2022078483A1 (zh) * 2020-10-15 2022-04-21 江苏恩华络康药物研发有限公司 甾体季铵化合物及其制备方法、制剂和用途
CN116925171B (zh) * 2023-07-10 2025-06-27 时森海(杭州)医药科技有限公司 含环丙甲基甾体类季铵盐化合物、中间体及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1138605A (en) * 1965-02-19 1969-01-01 Organon Labor Ltd Improvements in or relating to new 2-ß,16-ß-diamino-androstanes
GB1454749A (en) * 1972-11-29 1976-11-03 Akzo Nv 2beta, 16beta-diamino-androstanes and their preparation
HU171166B (hu) * 1975-07-15 1977-11-28 Richter Gedeon Vegyeszet Sposob poluchenija novykh ehpoksi-androstanov
US4177190A (en) * 1975-08-01 1979-12-04 Richter Gedeon Vegyeszeti Gyar Rt. Diamino-androstanes and a process for the preparation of the said compounds
HU172522B (hu) * 1975-08-01 1978-09-28 Richter Gedeon Vegyeszet Sposob poluchenija novykh proizvodnykh 2beta, 16beta-diamino-androstana i ikh chetvertichnykh solej

Also Published As

Publication number Publication date
ATE921T1 (de) 1982-05-15
EP0008824A1 (en) 1980-03-19
GR72520B (https=) 1983-11-16
FI66881B (fi) 1984-08-31
NZ191462A (en) 1982-03-16
IL58080A0 (en) 1979-12-30
JPS6245879B2 (https=) 1987-09-29
AU526270B2 (en) 1982-12-23
NO151367C (no) 1985-03-27
US4297351A (en) 1981-10-27
US4237126A (en) 1980-12-02
DK361779A (da) 1980-03-06
NO792810L (no) 1980-03-06
CA1134813A (en) 1982-11-02
EP0008824B1 (en) 1982-04-28
DE2962627D1 (en) 1982-06-09
HU181847B (en) 1983-11-28
PH16041A (en) 1983-06-02
JPS5535098A (en) 1980-03-11
IL58080A (en) 1982-12-31
FI792745A7 (fi) 1980-03-06
PT70126A (en) 1979-09-01
AU5034879A (en) 1980-03-13
DK159119C (da) 1991-03-11
IE791593L (en) 1980-03-05
NO151367B (no) 1984-12-17
DK159119B (da) 1990-09-03
AR228728A1 (es) 1983-04-15
ZA794371B (en) 1980-08-27
ES483894A1 (es) 1980-09-01
FI66881C (fi) 1984-12-10

Similar Documents

Publication Publication Date Title
EP0008824B1 (en) Acid addition salts of 16-beta-monoquaternary ammonium derivatives of 2-beta, 16-beta-bis-piperidino-androstanes and pharmaceutical preparations containing same
US5760072A (en) Paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy
PL175591B1 (pl) Środek farmaceutyczny do hamowania 5alfa-reduktazy testosteronowej
KR20150053982A (ko) 올레아놀산의 ｃ１７―헤테로아릴 유도체 및 그의 사용 방법
KR960015037B1 (ko) C_17 내지 C_20 리아제 억제제로서 유용한 17β-(사이클로프로필아미노)안드로스트-5-엔-3β-올 및 관련 화합물
US5075464A (en) 17β-(cyclopropylamino)androstene derivatives
EP0256668A2 (en) Method for treating male sexual dysfunction
Anderson et al. Strategies in the design of solution-stable, water-soluble prodrugs I: a physical-organic approach to pro-moiety selection for 21-esters of corticosteroids
US3867364A (en) Process for the synthesis of leupeptins and their analogues
US4272525A (en) Derivatives of polyene macrolide antibiotics containing an amino sugar moiety, process for the preparation thereof, and pharmaceutical compositions containing them
US4622218A (en) Testicular-specific drug delivery
JPS58189200A (ja) ９α−ハロ−１６−メチルプレドニソロンのエステル類の製造法
US4913852A (en) Compounds obtained from the associative synthesis of sulfur-containing or sulfur-free amino acids with pregnane derivatives
EP0228625B1 (de) Peptid-Derivate mit inhibitorischer Wirkung auf hydroxylierende Enzyme, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und ihre Verwendung
Johnson et al. Solution kinetics of a water-soluble hydrocortisone prodrug: hydrocortisone-21-lysinate
EP0010297B1 (en) Derivatives of polyene macrolide antibiotics containing an amino sugar moiety, process for the preparation thereof, and pharmaceutical compositions containing them
US5869475A (en) Certain 3-ketosteroids used to inhibit steroid 5α-reductase
US4891366A (en) Novel 2β,16β-diamino-androstanes
US4440764A (en) Water soluble esters of steroid-oxazole and pharmaceutical compositions containing them
HU193291B (en) Process for production of biologically active heptapeptides and their acid-additional salts and medical preparatives containing thereof as active substance
Stark et al. Enzyme-catalyzed prodrug approaches for the histamine H3-receptor agonist (R)-α-methylhistamine
Yoon et al. Steroidal anti-inflammatory antedrugs: Synthesis and pharmacological evaluation of 16α-alkoxycarbonyl-17-deoxyprednisolone derivatives
CS266597B2 (en) Method of pregnale-21-acid's 16,17-acetal-substituted derivatives production
EP0349869A2 (en) Process for production of 1alfa, 3beta, 24-trihydroxy-delta5-steroids
US4632820A (en) Novel radioactive estratrienes

Legal Events

Date Code Title Description
MK9A Patent expired